A novel human protein of the maternal centriole is required for the final stages of cytokinesis and entry into S phase by Gromley, Adam et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/05/535/11 $8.00
The Journal of Cell Biology, Volume 161, Number 3, May 12, 2003 535–545
http://www.jcb.org/cgi/doi/10.1083/jcb.200301105
 
JCB
 
Article
 
535
 
A novel human protein of the maternal centriole is 
required for the ﬁnal stages of cytokinesis and entry 
into S phase
 
Adam Gromley,
 
1
 
 Agata Jurczyk,
 
1
 
 James Sillibourne,
 
1
 
 Ensar Halilovic,
 
1
 
 Mette Mogensen,
 
3
 
 Irina Groisman,
 
1
 
 
Maureen Blomberg,
 
2
 
 and Stephen Doxsey
 
1
 
1
 
Department of Molecular Medicine and 
 
2
 
Department of Cell Biology, University of Massachusetts Medical School, 
Worcester, MA 01605
 
3
 
School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK
 
entrosomes nucleate microtubules and contribute to
mitotic spindle organization and function. They also
participate in cytokinesis and cell cycle progression
in ways that are poorly understood. Here we describe a
novel human protein called centriolin that localizes to the
maternal centriole and functions in both cytokinesis and
cell cycle progression. Centriolin silencing induces cyto-
kinesis failure by a novel mechanism whereby cells remain
interconnected by long intercellular bridges. Most cells
continue to cycle, reenter mitosis, and form multicellular
syncytia. Some ultimately divide or undergo apoptosis
C
 
speciﬁcally during the protracted period of cytokinesis. At
later times, viable cells arrest in G1/G0. The cytokinesis
activity is localized to a centriolin domain that shares
homology with Nud1p and Cdc11p, budding and ﬁssion
yeast proteins that anchor regulatory pathways involved in
progression through the late stages of mitosis. The Nud1p-
like domain of centriolin binds Bub2p, another component
of the budding yeast pathway. We conclude that centriolin
is required for a late stage of vertebrate cytokinesis, perhaps
the ﬁnal cell cleavage event, and plays a role in progression
into S phase.
 
Introduction
 
Centrosomes are the major microtubule-nucleating organelles
in most vertebrate cells (Doxsey, 2001b). In mitosis, they
contribute to spindle organization and function, and in
interphase, they organize microtubule arrays that serve as
tracks for transporting proteins, organelles, and chromo-
somes. The centrosome also anchors regulatory molecules
and may serve as a central site that receives, integrates, and
transmits signals that regulate fundamental cellular functions.
The core of the centrosome is comprised of a pair of centrioles,
microtubule barrels that appear to anchor microtubules
(Chretien et al., 1997; Piel et al., 2000). Each centriole is
surrounded by pericentriolar material or centrosome matrix,
which nucleates the growth of new microtubules and seems
to be organized by the centrioles (Bobinnec et al., 1998).
Although best known for their role in microtubule nucleation,
recent data suggest that centrosomes also play key roles in
cytokinesis and cell cycle progression.
A role for centrosomes in defining the site of cell cleav-
age during cytokinesis has been suggested for some time
(Rappaport, 1986). Recent studies with vertebrate cells provide
evidence for a direct link between centrosome activity and
completion of cytokinesis. Elimination of centrosomes from
interphase cells by removal with a microneedle (Hinchcliffe
et al., 2001) or from mitotic cells by laser ablation (Khodjakov
and Rieder, 2001) caused cytokinesis defects, arrest, or failure.
In another study, it was shown that during the final stages of
cytokinesis, the maternal centriole moved to the intercellular
bridge, the microtubule-filled interconnection between nascent
daughter cells (Piel et al., 2001). Centriole repositioning
correlated with bridge narrowing and microtubule depoly-
merization, while movement of the centriole away from the
bridge correlated with cell cleavage or abscission. The authors
suggested that the maternal centriole might anchor a regulatory
pathway that controls the final stages of cell division in
vertebrate cells. This would be analogous to regulatory
pathways anchored at spindle pole bodies (the centrosome
equivalent) in budding and fission yeasts that control mitotic
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exit and cytokinesis (for reviews see Bardin and Amon,
2001; McCollum and Gould, 2001; Pereira and Schiebel,
2001). However, no vertebrate pathway analogous to the
mitotic exit network (MEN)* in budding yeast or septation
initiation network (SIN) in fission yeast has been identified
(Glotzer, 2001; Guertin et al., 2002). Moreover, the role of
centrosome-associated molecules in the process of cytokine-
sis is poorly understood.
In addition to their role in cytokinesis, centrosomes ap-
pear to have a role in cell cycle progression. Recent evidence
demonstrates that vertebrate cells lacking centrosomes do
not initiate DNA replication (Hinchcliffe et al., 2001;
Khodjakov and Rieder, 2001). The authors suggested that
centrosomes controlled entry into S phase by recruiting or
concentrating “core” centrosome molecules required for this
process or that they indirectly activated a cellular checkpoint
that monitored aberrant centrosome number. In another ex-
perimental system, vertebrate cells treated with cytochalasin
D to inhibit actin-mediated cell cleavage also arrested cells in
G1 as binucleate cells with supernumerary centrosomes (An-
dreassen et al., 2001). Although these results suggest that
changes in centrosome number can affect entry into S phase,
the precise role of centrosomes in cell cycle progression in
vertebrate cells will require identification of the molecular
components and pathways that control these events.
In this paper, we identify a novel component of the verte-
brate maternal centriole called centriolin. Abrogation of cen-
triolin function by small interfering RNA (siRNA) silencing,
overexpression, or antibody inhibition produces cytokinesis
failure and G1/G0 arrest, just as seen when centrosomes are
experimentally eliminated from cells. Centriolin silencing
produces a novel cytokinesis phenotype in which dividing
cells remain interconnected by long strands of cytoplasm
and fail to cleave. The cytokinesis activity lies in a centriolin
domain that is homologous to the MEN/SIN components
Nud1p/Cdc11p and binds the Nud1p-interacting GTPase-
activating protein Bub2p. We conclude that centriolin is re-
quired for a distinct step in the final stages of vertebrate cy-
tokinesis and can influence entry into S phase.
 
Results
 
Identification and cloning of a novel protein localized 
to the maternal centriole and intercellular bridge
 
Using sera from patients with the autoimmune disease sclero-
derma that react with centrosomes (Doxsey et al., 1994), we
screened a human placenta 
 
 
 
gt11 cDNA expression library
to identify genes encoding the autoantigens. Of the 3 
 
 
 
 10
 
6
 
clones screened, only one of 1.7 kb was identified, indicating
that the mRNA for this molecule was rare. The full-length
cDNA was obtained, and the protein encoded by the cDNA
was called centriolin (see below and Materials and methods).
The amino acid sequence of centriolin predicted a protein
with several coiled-coil regions interrupted by noncoiled
domains (Lupas et al., 1991) (Fig. 1 a). Two domains within
the centriolin sequence shared homology with human onco-
genic transforming acidic coiled-coil proteins (TACCs),
which localize to centrosomes and are implicated in micro-
tubule stabilization and spindle function (Lee et al., 2001).
Another domain of centriolin was homologous to human
stathmin, an oncogenic protein involved in microtubule de-
stabilization (Andersen, 2000). The carboxy terminus of
centriolin was identical to CEP110, a naturally occurring fu-
sion to the fibroblast growth factor receptor that localizes to
centrosomes, is oncogenic, and is of unknown function (Gu-
asch et al., 2000). The relationship of CEP110 to centriolin
is unknown, although we did not identify a cDNA corre-
sponding to this protein in our library screens. A region of
centriolin near the amino terminus shared homology with
Nud1p and Cdc11p, budding and fission yeast spindle pole
body proteins that anchor components of the yeast MEN
and SIN, respectively, and are required for completion of
mitosis and cytokinesis (Bardin and Amon, 2001; McCol-
lum and Gould, 2001; Pereira and Schiebel, 2001; Guertin
et al., 2002). The 120–amino acid region of shared homol-
ogy between the Nud1 domain, Nud1p, and Cdc11p all
have leucine-rich repeats and are predicted to form 
 
 
 
 helix
structures in tertiary structure prediction programs.
Antibodies raised against recombinant centriolin recog-
nized a band of 
 
 
 
270 kD on Western blots of isolated cen-
trosome fractions, whereas preimmune sera showed no
specific bands (Fig. 1 b, Centrosome fractions). In vitro
translation and overexpression of the protein in mammalian
cells using the full-length cDNA produced a protein with a
molecular weight similar to the endogenous protein (Fig. 1
b, In vitro translated and Overexpressed) and to a protein
predicted from the cDNA sequence (see Materials and
methods).
Immunofluorescence microscopy demonstrated that cen-
triolin was localized to centrosomes in a wide variety of
species, including human, monkey, hamster, mouse, and
 
Xenopus
 
 (Figs. 1 and 2; unpublished data). Centrosome
localization was confirmed by showing that an HA-tagged
centriolin protein ectopically expressed in COS cells local-
ized to centrosomes (Fig. 2 a). The endogenous protein was
present on the centrosome throughout the cell cycle. In late
G1/early S phase, centrosomes begin to duplicate, and by
G2/M, duplication is usually completed. During the dupli-
cation process, centriolin was present on only one of the two
duplicating centrosomes, although other proteins, such as
 
 
 
-tubulin, were found on both (Fig. 1 c, G2 cell). Beginning
at late G2/prometaphase, dim staining was observed next to
a brightly stained centrosome. By metaphase, when cen-
trosomes become “mature,” both centrosomes had equally
high levels of centriolin and were more brightly stained than
at any other cell cycle stage. This demonstrates that centrio-
lin is a marker for centrosome maturation, a characteristic
shared with cenexin (Lange and Gull, 1995) and ninein
(Mogensen et al., 2000). At the metaphase to anaphase tran-
sition, centriolin staining diminished at centrosomes and
reached its lowest levels by late anaphase/telophase. During
cytokinesis, centriolin sometimes appeared as one or two
dots adjacent to the intercellular bridge, suggesting that the
centrosome/centriole had moved to this site (Fig. 1 c, Telo
early). This staining pattern was consistent with recent time-
 
*Abbreviations used in this paper: MEN, mitotic exit network; RPE,
retinal pigment epithelial; SIN, septation initiation network; siRNA,
small interfering RNA; TACC, transforming acidic coiled-coil protein;
TAD, transactivation domain.T
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lapse imaging experiments showing that the maternal centri-
ole translocates to the intercellular bridge during cytokinesis
(Piel et al., 2001). Centriolin next appeared as diffusely orga-
nized material within the intercellular bridge and ultimately
became concentrated at the midbody (Fig. 1 c, Telo late).
The organization of centriolin at the centrosome was
more precisely determined by serum starving cells to induce
growth of a primary cilium from the maternal centriole
(Vorobjev and Chentsov, 1982). In these cells, centriolin
staining was confined to the maternal centriole underlying
the cilium (Fig. 2 b). Immunogold electron microscopy on
centrosome fractions (Doxsey et al., 1994; Blomberg-Wir-
schell and Doxsey, 1998) confirmed localization to the ma-
ternal centriole (Fig. 2 e, M) and further demonstrated that
the protein was concentrated on subdistal appendages, spe-
cialized substructures of the maternal centriole implicated in
microtubule anchoring (Fig. 2, c–e) (Chretien et al., 1997;
Piel et al., 2000). Based on its centriolar localization, the
protein was named centriolin. Centriolin was also found at
noncentrosomal apical bands of material in specialized epi-
thelial cells that lack proteins involved in microtubule nucle-
ation and appear to anchor the minus ends of microtubules
(Mogensen et al., 1997) (Fig. 2, f and g).
 
Centriolin silencing by siRNA induces cytokinesis 
failure and a novel cytokinesis phenotype
 
To determine the function of centriolin, we reduced its levels
using siRNAs (Fire et al., 1998; Elbashir et al., 2001). Treat-
ment of telomerase-immortalized diploid human retinal pig-
ment epithelial (RPE-1) cells (Morales et al., 1999) with cen-
Figure 1. Centriolin is an  270-kD 
coiled-coil protein localized to mature 
centrosomes and the midbody. (a, top) 
Schematic showing centriolin domains 
that share homology with budding and 
fission yeast proteins Nud1p and 
Cdc11p, human stathmin, and human 
and Drosophila TACCs. Percentages 
represent identities and similarities of 
centriolin to the homologous proteins 
described above. (a, bottom) Schematic 
showing centriolin regions predicted to 
be coiled coil. Below both diagrams are 
centriolin amino acid numbers. (b, In 
vitro translated) [
35S]methionine-labeled 
HA-tagged centriolin produced by in 
vitro translation of cDNA and resolved 
directly (Cen) or after immunoprecipitation 
with HA antibodies (Cen IP); empty 
vector (Vec). (b, Overexpressed) Western 
blots probed with anti-HA antibody 
showing overexpressed HA-tagged 
centriolin (HA-Cen) and its absence from 
cells overexpressing  -galactosidase 
(  gal). (b, Centrosome fractions) Centro-
some fractions prepared from HeLa cells 
and Xenopus tissue culture (XTC) cells 
blotted with antibodies to centriolin 
(Cen) or preimmune sera (PreI). Arrow-
heads show position of centriolin. In 
XTC cells, the bands below centriolin 
appear to be degradation products as 
they are sometimes observed in protein 
fractions produced by in vitro translation 
or overexpression. Bars represent positions 
of molecular weight markers ( 10
3). 
(c) Immunofluorescence images of 
endogenous centriolin in RPE-1 cells at 
different cell cycle stages. The top panels 
show merged images of centriolin (green), 
 -tubulin (red), and nuclei (blue) from 
cells in G1, G2, proM (prometaphase), 
M (metaphase), and anaphase (A). Insets, 
higher magnifications of centrosomes 
stained for  -tubulin (left) and centriolin 
(right). Centriolin localization to one of the two centrosomes is demonstrated most clearly in the G2 cell. Middle panels (Telo early) and 
bottom panels (Telo late) show separate images of  -tubulin staining (left) and centriolin (right).  -Tubulin marks both mother and daughter 
centrioles, which are separated in some cases. Centriolin staining is confined to one of two centrioles, which sometimes appears at the intercellular 
bridge (Telo early). Centrioles lacking centriolin are indicated by arrowheads in right panels. At later stages of telophase (Telo late), centriolin 
is also on the midbody. All immunofluorescence images (here and elsewhere) are two-dimensional projections of three-dimensional 
reconstructions to ensure that all stained material is visible. C, centriole; MB, midbody. Bar in c, 10  m; but 3  m for insets.T
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triolin-specific siRNAs caused a significant reduction in
centriolin mRNA levels (Fig. 3 a). Although we were unable
to examine protein levels by Western blotting of whole cell ly-
sates due to the rare nature of this and other centrosome au-
toantigens (Doxsey et al., 1994), immunofluorescence stain-
ing demonstrated that centriolin was undetectable, or greatly
reduced, at centrosomes in most cells (86%; 
 
n
 
 
 
 
 
 1,012).
Quantitative analysis showed that immunofluorescence sig-
nals at individual centrosomes were significantly below those
in cells treated with control lamin A/C siRNA, despite severe
disruption of the nuclear lamina in the latter (Fig. 3 b) (El-
bashir et al., 2001). Midbody staining of centriolin was also
reduced in cells treated with siRNAs targeting centriolin.
Because centriolin shares homology with proteins known
to affect microtubule organization and cytokinesis, we exam-
ined cells with reduced centriolin for defects in these func-
tions. The most obvious cellular change detected in RPE-1
cells with reduced centriolin was a dramatic increase in the
percentage of late-stage mitotic cells (
 
 
 
70-fold increase; Fig.
3 c). In addition, we observed an increase in the percentage
of binucleate cells in three different cell lines, suggesting that
a certain proportion of cells failed to cleave (Fig. 3 d; see be-
low). The incidence of binucleate cells was significantly
greater than controls, although somewhat lower than that
observed for some other proteins involved in cytokinesis
(Matuliene and Kuriyama, 2002; Meraldi et al., 2002; Mol-
linari et al., 2002). A similar cytokinesis phenotype was ob-
served with a second set of siRNAs targeting a different
centriolin sequence and with morpholino antisense DNA
oligonucleotides targeting centriolin.
The dramatically high percentage of cells in late mitotic
stages suggested a unique cytokinesis defect in these cells.
When carefully analyzed by immunofluorescence micros-
copy, cells with reduced centriolin appeared to be arrested or
delayed in the final stages of cytokinesis. Most cells retained
intercellular bridges of varying length and thickness (Fig. 3,
m and n, arrowheads). In some cases, cells remained con-
nected even though one or both of the future daughter cells
had reentered mitosis (Fig. 3 n, M). Some cells failed to
cleave, forming syncytia with two, three, of four cells re-
maining interconnected (Fig. 3, m and n). During the early
stages of cytokinesis, midbodies appeared normal.
A more complete understanding of the mechanism of cy-
tokinesis failure was obtained by imaging live HeLa cells
treated with centriolin-specific siRNAs (Fig. 4; see Vid-
eos  1–3, available at http://www.jcb.org/cgi/content/full/
jcb.200301105/DC1). As expected, control cells (lamin
siRNA) performed a distinct cell cleavage event with normal
timing (average 2 h after mitosis) and immediately flattened
and crawled apart (Fig. 4 a). Cells silenced for centriolin
progressed normally through mitosis (Fig. 3, g–j; Fig. 4 e)
and sometimes cleaved normally, but most failed to cleave or
cleaved after prolonged periods of time (up to 23.2 h after
metaphase; Fig. 4, b–d and f). These cells arrested or delayed
in a unique post-telophase state. Most were unusually elon-
gated, each with a persistent intercellular bridge of variable
diameter that was often dynamic. Bridges alternated be-
tween thin threads of interconnecting cytoplasm to very
thick interconnections of large diameter that appeared able
to produce membrane ruffles (Fig. 4 b, 5:50, arrow). Mid-
Figure 2. Centriolin is localized to maternal 
centrioles and noncentrosomal sites of 
microtubule anchoring. (a) HA-tagged 
centriolin overexpressed in COS-7 cells 
localizes to the centrosome (anti-HA, green) 
at the convergence of microtubules (red, 
anti– -tubulin). (b) An RPE-1 cell immuno-
stained with an antibody to polyglutamylated 
tubulin (GT335) (Bobinnec et al., 1998) to 
label centrioles and the primary cilium (red), 
and for centriolin (green), which is localized 
to the maternal centriole (m) associated with 
the primary cilium (yellow in merge) but not 
on the daughter centriole (d). n, nucleus. (c–e) 
Electron micrographs showing specific 
immunogold labeling of centriolin on sub-
distal appendages found on maternal (e, 
bottom, M) but not daughter centrioles (e, 
top, D). c and d are longitudinal and cross 
sections, respectively, through maternal 
centrioles, and e is a longitudinal section 
through both centrioles. Arrowheads show 
striations characteristic of subdistal append-
ages. (f and g) Centriolin is found at non-
centrosomal sites of microtubule anchoring 
in pillar cells of the mouse cochlea (arrows) 
(Mogensen et al., 1997). (f) Schematic 
representation of a pillar cell. (g) Centriolin 
immunofluorescence staining overlaid with 
phase contrast image. Centrosome and 
associated cilium are shown schematically 
at top of cell in f. Bars: (a and g) 10  m; 
(b) 2  m; (c–e) 100 nm.T
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bodies were not detected within persistent interconnections
between cells, suggesting that they were lost sometime dur-
ing the protracted period spent in cytokinesis. Intercon-
nected cells sometimes coalesced to form single cells and
then quickly moved apart again (Fig. 4 d). They sometimes
made multiple failed attempts at cleavage, but in no case did
we observe a cell that formed a stable binucleate. This sug-
gested that binucleate cells observed in fixed cells (Fig. 3 d)
were transient intermediates in a process that involved mul-
tiple failed attempts at cytokinesis. Cells that retained inter-
cellular connections for long periods of time continued to
progress through the cell cycle. To our surprise, some cells
reentered the next mitosis while still interconnected and
produced interconnected “progeny” that formed two- to
four-cell syncytia, thus confirming the cell–cell interconnec-
tions observed by indirect immunofluorescence (Fig. 3, m
and n). In some cases, cells that remained interconnected for
long periods of time appeared to undergo apoptosis. They
showed extensive blebbing, increased phase density, and de-
creased size and lifted from the substrate (Fig. 4 b, upper
cell, 7:20).
Microtubule organization in cells with reduced centriolin
appeared normal at all cell cycle stages. This included micro-
tubules of the spindle midzone in anaphase and the mid-
body in telophase (Fig. 3, e–j). Microtubule nucleation from
centrosomes also appeared normal (Fig. 3, k and l), although
a slight delay was sometimes observed within the first
minute or two. 
 
 
 
-Tubulin, a marker for centrosome-associ-
ated microtubule nucleation, was localized normally to cen-
trosomes (Fig. 3 b), as were several other centrosome anti-
gens, including GCP-2 (Murphy et al., 1998) and cNap-1
(Fry et al., 1998) (unpublished data). Midbody markers,
such as anillin (see Glotzer, 2001) and 
 
 
 
-tubulin (Shu et al.,
1995), were also localized normally. At later stages of cytoki-
Figure 3. RPE-1 cells treated with siRNAs 
targeting centriolin retain persistent inter-
cellular connections and fail in cytokinesis. 
(a) RT-PCR analysis shows that centriolin mRNA 
is reduced in RPE-1 cells treated with centriolin-
specific siRNAs (top right) but is unaffected in 
cells treated with siRNAs targeting lamins A/C 
(top left, sequence identity confirmed). Control 
( -tubulin) RT-PCR was performed in the same 
reaction mixtures with centriolin and lamin 
(bottom panels). (b) Immunofluorescence 
images (top right;  -tubulin, red; centriolin, 
green) and quantification of centriolin levels 
in centrosomes from cells treated with siRNAs 
as indicated. The top right panel shows a cell 
with undetectable centriolin at the centrosome/
centriole, and the top left panel shows a cell 
that is unaffected by the treatment and stains 
for centriolin (green/white). Graph shows the 
average centriolin fluorescence intensity/pixel 
at individual centrosomes (bars) in cells 
treated with lamin or centriolin siRNAs. The 
centrosome fluorescence in most centriolin 
siRNA–treated cells (83%) was below the 
lowest values observed in control cells. 
(c) Graph showing a dramatic increase in 
the percentage of cells in telophase/cytokinesis 
after siRNA targeting of centriolin ( 70-fold). 
n, total number of cells counted (c and d). 
(d) Graph showing the increased percentage 
of binucleate cells in HeLa, U2OS, and RPE-1 
cell lines after treatment with centriolin siRNAs 
(4–15-fold greater than controls). In c and d, 
values represent data from single experiments 
representative of three to four experiments. 
The time analyzed was as follows: HeLa, 48 h 
and 72 h; U2OS, 72 h; RPE-1, 24 h. (e–l) 
Microtubule organization (e–j) and microtubule 
nucleation (k and l) are not detectably altered 
in cells treated with centriolin siRNA (f, h, j, 
and l) compared with cells treated with lamin 
siRNA (e, g, i, and k). Arrows indicate position 
of centrosomes; no centrosome staining is observed in centriolin siRNA–treated cells. Insets in k and l are enlargements of centriolin staining 
at centrosomes (or microtubule convergence sites) at arrows. Cells in interphase (e and f, lower cell), prometaphase/metaphase (proM/M; g 
and h), and telophase (i and j) were labeled for microtubules (red), centrosomes (green/yellow), and nuclei (blue). MB, midbody. (m and n) 
Cells treated with siRNAs targeting centriolin were stained for microtubules (red) and DNA (blue). Arrowheads indicate contiguous connections 
between two or more cells. (m) Three interconnected cells form a syncytium. (n) One daughter of an interconnected pair of cells has reentered 
mitosis (M). Bar in n: (e–j) 5  m; (k, l, and insets) 3.5  m; (m and n) 15  m.T
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nesis in cells with long intercellular bridges, midbodies were
no longer detected. These data indicate that cytokinesis fail-
ure did not result from disruption of microtubules, cen-
trosomes, or midbodies.
 
Overexpression of centriolin and its Nud1
domain induces cytokinesis failure in a
microtubule-independent manner
 
We next tested the effect of ectopic expression of centriolin
and its Nud1 domain on cytokinesis and microtubule or-
ganization (Fig. 5, a–g). The most striking defects in COS-7
cells expressing HA-tagged centriolin were an increase in
the proportion of telophase cells and the formation of bi-
nucleate cells (Fig. 5 g). Microtubule bundles were ob-
served within intercellular bridges in telophase cells (Fig. 5
a), but they did not appear to cause binucleate cell forma-
tion. We found that overexpression of the 120–amino acid
GFP-tagged Nud1 domain of centriolin was sufficient to
induce cytokinesis failure and binucleate formation (Fig. 5,
e and g) in the absence of detectable changes in microtu-
bule organization (Fig. 5, c and d) and without disrupting
endogenous centriolin from centrosomes (Fig. 5 f). The re-
sults from gene silencing and protein overexpression sup-
port a microtubule-independent mechanism for cytokine-
sis failure.
 
The centriolin Nud1 domain interacts with the yeast 
Bub2p in vitro
 
Budding yeast Nud1p anchors the MEN to the spindle pole
body through direct interactions with Bub2p and perhaps
other MEN components (Gruneberg et al., 2000; Pereira et
al., 2000). To determine if the centriolin Nud1 homology
domain (Fig. 5 h) had similar properties, we tested its ability
to bind Bub2p by directed two-hybrid analysis and immu-
noprecipitation. Because no vertebrate Bub2p homologue
has been unequivocally identified (Cuif et al., 1999), we ex-
amined the ability of the centriolin Nud1 domain to interact
with yeast Bub2p. Both two-hybrid analysis and immuno-
Figure 4. Time-lapse images of HeLa 
cells treated with centriolin siRNAs 
reveal unique cytokinesis defects. (a) A 
cell treated with control siRNAs targeting 
lamin moves apart, forms visible mid-
bodies (arrow), and completes the final 
cleavage event with normal timing 
(1–3 h after metaphase). (b–d) Centriolin 
siRNA–treated cells remain attached for 
extended periods of time through persis-
tent intercellular bridges and sometimes 
do not show visible midbodies. (b) A cell 
that remains attached by a long inter-
cellular bridge for at least 8 h. The cell 
cleaves, both daughter cells round up, 
and at least one appears to undergo 
apoptotic cell death (upper cell, 7:20, 
extensive blebbing and decrease in size). 
(c) A dividing cell that has not completed 
cleavage reenters the next mitosis. One 
cell rounds up and is drawn to the other. 
The other rounds up and both undergo 
the early stages of cytokinesis to form a 
total of four cells; these progeny often 
remain attached by intercellular bridges 
forming syncytia. (d) Cell showing three 
failed attempts at cell cleavage over a 
9.5-h time period. (e) Cells treated with 
siRNAs targeting centriolin progress from 
nuclear envelope breakdown (NEB) to 
anaphase with normal timing, similar 
to lamin siRNA controls. Vertical bars 
represent recordings from single cells 
(e and f). (f) Centriolin siRNA–treated 
cells are delayed in cytokinesis ( 70%) 
compared with control lamin siRNA–
treated cells, a value consistent with a 
70–80% silencing efficiency. Results 
represent recordings of individual cells 
from several independent experiments. 
Time in hours and minutes is included 
in each panel in a–d. Bar, 10  m. Time-
lapse videos (Videos 1–3) of the series 
of images shown in a–c are available at 
http://www.jcb.org/cgi/content/full/
jcb.200301105/DC1.T
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precipitation from yeast cells coexpressing the two proteins
revealed a strong and specific interaction between the centri-
olin Nud1 domain and Bub2p (Fig. 5, i and j). No signal
was observed when either protein was used alone, and no
binding was detected between the centriolin Nud1 domain
and the budding yeast MEN component Bfa1p, consistent
with interaction observations in budding yeast (Pereira and
Schiebel, 2001).
 
Cleavage failure is observed in 
 
Xenopus
 
 embryos 
injected with centriolin antibodies
 
A third approach was used to examine centriolin function.
When affinity-purified anticentriolin antibodies (Fig. 1 b)
were microinjected into one cell of two-cell 
 
Xenopus
 
 em-
bryos (Doxsey et al., 1994), the injected cell failed to cleave,
or cleaved a few times and then arrested; uninjected cells or
preimmune IgG-injected cells divided normally (Fig. 6, a
Figure 5. Cells expressing centriolin fail in cyto-
kinesis, as do cells expressing the centriolin Nud1 
domain that interacts with yeast Bub2p. (a) COS-7 
cell overexpressing HA-tagged centriolin (left inset) 
showing persistent microtubule bundles in the 
intercellular bridge during cytokinesis (main panel, 
 -tubulin staining) despite reformation of the 
nucleus and decondensation of chromatin (DNA, 
right inset). (b) Control COS-7 cell (expressing HA 
alone, bottom center) at a similar cell cycle stage 
based on nuclear morphology (bottom right) shows 
a narrow intercellular bridge and diminished 
microtubule polymer (center), characteristic of cells 
that have reformed nuclei and decondensed DNA. 
(c–f) COS-7 cells expressing a GFP-tagged Nud1 
domain of centriolin (c and d, insets, green; DNA, 
blue) have normal intercellular bridges (d, telophase, 
arrowhead) and normal microtubule organization 
(c, interphase) as in controls. However, the cells 
(yellow) often become binucleate (blue) by a 
mechanism that does not involve disruption of 
the endogenous centrosome-associated centriolin 
(f; right inset shows enlargement of centrosome, 
left inset shows transfected cell). (g) Quantitative 
analysis showing that HA–centriolin and the GFP-
tagged Nud1 domain both induce significant 
binucleate cell formation compared with controls 
(HA and GFP). Values are from a single experiment 
and are representative of three experiments. Bar, 7 
 m (for all panels). n, total number of cells counted. 
(h) Alignment of the centriolin Nud1 domain with 
the yeast Nud1p and Cdc11p proteins. (i) Direct 
yeast two-hybrid analysis demonstrates an inter-
action between the human Nud1 domain with one 
of the two components implicated in GTPase-
activating protein activity, Bub2p, but not Bfa1p. The blue colony in the blue box and increased  -galactosidase activity (bar 2 of graph) 
demonstrate a specific interaction between the human centriolin Nud1 domain (hNud1) and yeast Bub2p. Bar 1, LexA–BUB2   TAD; bar 2, 
LexA–BUB   TAD–hNud1; bar 3, LexA–BFA1   TAD; bar 4, TAD–hNud1   LexA–BFA1; bar 5, TAD-hNud1   LexA. (j) Specific coimmuno-
precipitation of HA-tagged hNud1 and LexA-tagged yeast Bub2p from yeast cells. Coprecipitation was observed using antibodies to either 
protein and only when both were coexpressed (top middle panel in each group). Lane 1, TAD–HA–hNud1   LexA; lane 2, TAD–HA–hNud1 
  Bub2p–LexA; lane 3, TAD–HA   Bub2p–LexA.
Figure 6. Cytokinesis failure in Xenopus embryos 
injected with centriolin antibodies. (a) Xenopus two-
cell embryos injected into one cell with  50 nl anti-
centriolin antibodies (2 mg/ml affinity purified) fail to 
cleave (arrows), whereas noninjected cells (side oppo-
site arrows) and cells injected with control rabbit IgG 
(2 mg/ml, top) cleave normally. (b and c) Immuno-
fluorescence images showing two microtubule asters 
near a single nucleus (N) in a cell from an embryo 
injected with control IgG (b), and two nuclei and two 
asters in a cell from a centriolin antibody–injected cell 
(c, microtubules stained with anti– -tubulin). Bar, 10 
 m (for b and c). (d) Quantification of results from 
injection experiments showing an approximately eight-
fold increase in cleavage failure (representative of three 
experiments). n, number of embryos examined.T
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and d). Centriolin antibody–injected cells arrested with two
nuclei and two well-organized microtubule asters, indicating
that karyokinesis and microtubule organization were nor-
mal, but cells failed to complete the final event of mitosis,
cell cleavage (Fig. 6 c). Preimmune IgG-injected cells had a
single nucleus with one or two microtubule asters, depend-
ing on their cell cycle stage, as would be expected for cells
that had undergone normal cell cleavage (Fig. 6 b). Taken
together, the results from gene silencing, antibody injection,
and protein overexpression in several experimental systems
all demonstrate that centriolin plays an important role in the
late stages of cytokinesis.
 
siRNA-induced gene silencing of centriolin 
causes G1/G0 arrest
 
Cytokinesis defects and delays induced by centriolin silenc-
ing were observed at early times after treatment of RPE-1
cells (18–24 h). At later times (48–72 h after treatment), a
reduction in the mitotic index was observed, suggesting that
the cells were arrested at some other stage of the cell cycle.
This was directly tested by treating cells with nocodazole to
induce mitotic arrest and quantifying mitotic cells in DAPI-
stained preparations. Under these conditions, most lamin
siRNA–treated control RPE-1 cells were arrested in mitosis
(71%), whereas only a small fraction of centriolin siRNA–
treated cells arrested at this cell cycle stage (
 
 
 
1%). To deter-
mine the cell cycle stage of arrest, cells were analyzed by flow
cytometry. In the presence of nocodazole, control cells
showed a significant shift from the G1 peak to the G2/M
peak (Fig. 7 a, red). In contrast, cells treated with siRNAs
targeting centriolin did not significantly shift into the G2/M
peak in the presence of nocodazole but remained largely in
G1 (Fig. 7 a, blue). The inability to undergo a nocodazole-
induced shift into the G2/M peak was a feature shared by
cells driven into G0 by serum starvation (Fig. 7 b, blue).
The proportion of cells in S phase was either unaltered or
slightly decreased in cells silenced for centriolin both in the
presence of nocodazole (centriolin, 13%; lamin, 23%) or in
its absence (centriolin, 13%; lamin, 19%). These results
demonstrate that cells with reduced centriolin arrest before S
phase, possibly in G1/S, G1, or G0.
Ki-67 staining was also used to examine the stage of cell
cycle arrest. Ki-67 is an antibody directed against a nuclear
protein that stains cycling cells or cells arrested in cycle (e.g.,
G1/S or S phase; Gerdes et al., 1984) but not cells that are
quiescent (G0) or differentiated. As expected, nearly all un-
treated RPE-1 cells or control cells treated with siRNAs tar-
geting GFP or lamins A/C were positive for Ki-67 (Fig. 7, c
and d). However, most cells with reduced centriolin had un-
detectable levels of Ki-67 staining (Fig. 7, c and d). Taken
together, results from mitotic index assays, flow cytometry,
and Ki-76 staining in RPE-1 and HME-1 (human mam-
mary epithelia) cells (unpublished data) demonstrated that
reduction of centriolin levels prevented cells from entering S
phase and appeared to drive them out of cycle into a G0-like
state. This cell cycle arrest effectively prevents the initiation
of additional rounds of centrosome duplication in cells com-
promised by having diminished levels of centriolin.
 
Discussion
 
In this paper, we characterize centriolin, a maternal centriole
component whose disruption induces cytokinesis failure and
G1/G0 arrest. The ability of centriolin to induce this pheno-
type may provide a molecular explanation for the cytokinesis
defects and G1 arrest previously observed in vertebrate cells
after experimental removal of entire centrosomes (Hinch-
cliffe et al., 2001; Khodjakov and Rieder, 2001). Moreover,
association of centriolin with the maternal centriole may be
a molecular requirement for activation and completion of
the final stages of cytokinesis, functions recently suggested
for the maternal centriole in vertebrate cells (Piel et al.,
2001).
The cytokinesis phenotype observed in cells treated with
siRNAs targeting centriolin is uncommon among proteins
that function in cytokinesis. The predominant phenotype
observed after functional abrogation of most proteins that
cause cytokinesis failure is coalescence of dividing cells into a
single cell with two nuclei. This has been shown for proteins
of the central spindle, regulatory proteins that control cyto-
kinesis, microtubule-associated proteins, and the centrosome
proteins 
 
 
 
-tubulin and centrin (Shu et al., 1995; Kaiser et
al., 2002; Manabe et al., 2002; Matuliene and Kuriyama,
2002; Meraldi et al., 2002; Mollinari et al., 2002; Salisbury
et al., 2002; Seong et al., 2002). In contrast, the predomi-
nant cytokinesis phenotype observed in cells with reduced
centriolin is failure to resolve persistent intercellular bridges
Figure 7. siRNAs targeting centriolin induce G1/G0 arrest. 
(a) RPE-1 cells treated with centriolin siRNAs (blue) do not shift into 
the G2/M peak after nocodazole treatment as seen for control lamin 
siRNA–treated cells (red). (b) The inability of cells treated with centriolin 
siRNAs to shift into the G2/M peak is similar to that observed in 
serum-starved cells (blue, serum starved; red, not starved). (c) Ki-67 
staining of control cells (left cell, green) occurs together with centriolin 
staining (left cell, red at arrow); both are gone in centriolin siRNA–
treated cells (right, arrowhead). Bar, 7.5  m. (d) Cells treated with 
siRNAs targeting centriolin lack Ki-67 staining ( 70%), whereas 
most control cells stain positively (GFP siRNAs). a, b, and d are 
representative experiments from five experiments for a, two for b, 
and three for d. n, total number cells counted.T
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between dividing cells. The apparent consequences of this
event are generation of multicellular syncytia, continuous at-
tempts at cell cleavage that include binucleate cells as inter-
mediates, completion of cytokinesis, perhaps artificially, by
traction-mediated cytokinesis (Burton and Taylor, 1997),
and apoptotic cell death. Although we have not determined
the precise mechanism of cytokinesis failure in cells with ab-
rogated centriolin function, we are testing whether mem-
brane is incorporated normally into the cleavage site (Finger
and White, 2002; Thompson et al., 2002).
Persistent intercellular bridges have also been observed
between dividing vertebrate cells overexpressing the Cdc-
14A phosphatase (Kaiser et al., 2002). This uncommon
phenotype has thus far been observed only with proteins
(centriolin and Cdc14A) that share homology with compo-
nents of yeast regulatory pathways that control mitotic exit
and cytokinesis (MEN/SIN) and localize to the same intra-
cellular sites as the yeast proteins (centrosome/spindle pole
bodies). Persistent intercellular connections may also be
present in cells lacking centrosomes and may reflect a simi-
lar type of cytokinesis defect (Doxsey, 2001a). Although
the mechanism of cytokinesis failure appears to be different
in SIN mutants, the outcome is the same, production of bi-
and multinucleate cells. These observations support the
idea that vertebrate cells may possess regulatory pathways
that function in much the same way as those in yeast to co-
ordinate the final stages of cytokinesis with chromosome
segregation.
Several domains of centriolin share sequence homology with
proteins implicated in tumorigenesis, including the TACCs
and oncoprotein 18/stathmin. In this paper, we show that the
domain homologous to Nud1p/Cdc11p can induce aneuploidy
through cytokinesis failure. This event could generate further
genetic instability through the organization of multipolar spin-
dles by supernumerary centrosomes and could thus facilitate the
accumulation of activated oncogenes and loss of tumor suppres-
sor genes (Pihan et al., 2001; Doxsey, 2002). We are currently
investigating the role of centriolin in human oncogenesis.
Our results suggest that minor changes in centrosome
composition, such as loss of centriolin, can arrest cells in
G1/G0. Because cells with reduced centriolin have difficulty
completing the final stages of cytokinesis, it is tempting to
suggest that G1/G0 arrest is a consequence of improper cy-
tokinesis. However, it has been suggested that G1 arrest in
cells lacking centrosomes may also result from the loss of
core centrosome components, improper spindle alignment,
or the presence of excess DNA in binucleate cells (Andreas-
sen et al., 2001; Hinchcliffe et al., 2001; Khodjakov and
Rieder, 2001; Meraldi et al., 2002). We are currently testing
a model in which the loss of core centrosome components
activates a checkpoint involved in monitoring “centrosome
integrity” and thus prevents centrosome duplication by ar-
resting cells in G1/G0, as we and others have proposed
(Doxsey, 2001a; Quintyne and Schroer, 2002).
 
Materials and methods
 
Cell culture and transfections
 
The cells used primarily in this study were diploid, telomerase-immortal-
ized human RPE-1 cells (hTERT–RPE-1s; CLONTECH Laboratories, Inc.)
(Morales et al., 1999). Other cells included HeLa, COS-7, hTERT–HME-1
(human mammary epithelia), U2OS, and 
 
Xenopus
 
 tissue culture (XTC)
cells. All were grown as previously described (American Type Culture Col-
lection). COS-7 cells were transfected as previously described (Lipo-
fectamine; Invitrogen).
 
Antibodies
 
Amino acids 268–903 or centriolin were fused with GST (CLONTECH
Laboratories, Inc.
 
)
 
, overexpressed in 
 
Escherichia coli
 
, and purified as previ-
ously described (Doxsey et al., 1994). Antibodies raised in rabbits were af-
finity purified by passing sera over a GST column to remove anti-GST anti-
bodies and then over a GST–centriolin column. Antibodies to the
following proteins were also used in this study: lamin A/C (Cell Signaling
Technology), 
 
 
 
- and 
 
 
 
-tubulins (Sigma-Aldrich), LexA (Santa Cruz Biotech-
nology, Inc.), GAL4 transactivation domain (TAD) (CLONTECH Laborato-
ries, Inc.), Ki-67, and HA (BD Biosciences).
 
Immunofluorescence and electron microscopy
 
Cells were prepared for immunofluorescence, imaged, and deconvolved
(Metamorph; Universal Imaging Corp.), and centrosomes were quantified
as previously described (Dictenberg et al., 1998). All immunofluorescence
images are two-dimensional projections of three-dimensional reconstruc-
tions to ensure that all stained material was visible in two-dimensional im-
ages. Immunogold electron microscopy was performed as previously de-
scribed (Doxsey et al., 1994) using centrosome fractions from HeLa cells
(Blomberg-Wirschell and Doxsey, 1998) and antibodies to centriolin fol-
lowed by antibodies coupled to 5-nm gold particles (Amersham Bio-
sciences). Pillar cells were prepared and stained as previously described
(Mogensen et al., 1997).
 
Centriolin cloning
 
A cDNA of 
 
 
 
1.7 kb was identified by screening a human placenta expres-
sion library with serum from individuals with scleroderma (Doxsey et al.,
1994). The nucleotide sequence was compared with others (blastn) in the
human genome database (National Center for Biotechnology Information)
and revealed a sequence with 99% identity on chromosome 9 q34.11–
34.13. Genscan predicted an 
 
 
 
7-kb gene comprising 40 exons. PCR prim-
ers were used to obtain an 
 
 
 
7-kb cDNA in a human testes cDNA library.
The 5
 
 
 
 end, obtained by rapid amplification of cDNA ends (RACE), was
identical to the predicted sequence. A full-length HA-tagged centriolin was
obtained by inserting an HA tag (YPYDVPDYASL) 5
 
 
 
 to the RACE fragment
and ligating the HA–centriolin cDNA to the original fragment. The full-
length centriolin cDNA contained 6,975 nucleotides with an ORF of 2,325
amino acids and predicted a molecular mass of 269 kD, consistent with
the molecular mass of endogenous centriolin (Fig. 1).
Regions flanking the ORF had a translational start (Kozak sequence),
polyadenylation sequence, poly-A tail, and multiple upstream and down-
stream stop codons. The construct was inserted into pcDNA 3.1 Zeo (
 
 
 
)
(Invitrogen) using BamHI and NotI restriction sites. Centriolin was trans-
lated in vitro (TNT; Promega) and expressed in cultured cells using con-
ventional procedures (Lipofectamine). Centriolin amino acids 435–623
and 1385–1658 were 24% identical/47% similar and 20% identical/41%
similar to the COOH-terminal half of TACCs, respectively. Amino acids
879–913 were 40% identical/51% similar to amino acids 72–106 of hu-
man stathmin. Amino acids 126–234 were 31–35% identical/47–50% sim-
ilar to Nud1p and Cdc11p.
 
siRNAs and morpholino antisense
 
siRNAs targeting centriolin, lamin A/C, and GFP mRNAs were made as
complimentary single-stranded 19-mer siRNAs with 3
 
 
 
 dTdT overhangs
(Dharmacon Research), deprotected, annealed, and delivered into cells us-
ing a 400 
 
 
 
M stock (Oligofectamine; Invitrogen). The nucleotides targeted
were as follows: in centriolin, 117–136 and 145–163; in lamin A/C, 608–
630; and in pEGFP-C1 (CLONTECH Laboratories, Inc.), 233–252.
Fluorescein-conjugated morpholino antisense DNA oligonucleotides
(Gene Tools) targeting the start codon of centriolin were introduced into
cells using the EPEI agent (Gene Tools). The inverse sequence was used as
control.
 
Time-lapse imaging
HeLa cells plated on coverslips (25 mm diameter) were treated with si-
RNAs targeting centriolin for 50 h. They were placed in a chamber (PDMI-2;
Harvard Apparatus) in complete medium with CO2 exchange (0.5 liters/
min) at 37 C. Cells were imaged every 10 min for 12–20 h using a 20  or
40  phase contrast lens with a green interference filter on an inverted mi-
croscope (Olympus IX-70). Images were captured on a CoolSnap HQ CCDT
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camera (Roper Scientific) and concatenated using Metamorph software
(Universal Imaging Corp.).
Primary cilium formation and microtubule nucleation
Primary cilia were induced by culturing hTERT–RPE-1 cells in medium
with 0.25% serum for 48 h and identified using the GT335 antibody raised
to polyglutamylated  - and  -tubulins (Bobinnec et al., 1998). Microtu-
bule nucleation was performed as previously described (Purohit et al.,
1999) by treatment with nocodazole (1 mg/ml) for 1 h at 37 C, fixing cells
at various times after washing out drug, and then staining for microtubules.
RT-PCR
Centriolin mRNA levels were assayed by RT-PCR using 10  l mRNA
(OneStep RT-PCR; QIAGEN);  -tubulin served as an internal control in the
same reaction. All products were sequenced.
Yeast two-hybrid analysis and immunoprecipitations
A fragment containing amino acids 127–233 of centriolin was cloned into
EcoRI and SalI sites of pGADT7 (CLONTECH Laboratories, Inc.) to pro-
duce a fusion with the GAL4 TAD. Constructs pEG202 (LexA), pGP69
(LexA-BUB2), and pGP122 (LexA-BFA1) and the yeast strain SGY37 were
from Elmar Schiebel (Paterson Institute for Cancer Research, Manchester,
UK). SGY37, which contains a LacZ reporter gene under the control of a
LexA operator, was transformed with plasmid DNA using LiAc (Ito et al.,
1983), and transformants were selected for on dropout medium. We used
semiquantitative  -galactosidase assays (Schramm et al., 2001) and more
quantitative  -galactosidase assays with CPRG (chlorophenol red- -D-
galactopyranoside; Roche) as a substrate per the manufacturer’s instruc-
tions. Coimmunoprecipitation of LexA and GAL4 TAD fusion proteins was
performed as previously described (Schramm et al., 2001).
Flow cytometry
Cells treated with siRNAs for 50–70 h were treated with 100 ng/ml for
12 h, removed from plates, and fixed in methanol. Cells stained with pro-
pidium iodide were analyzed by flow cytometry (FACSCAN
®; Becton
Dickinson) using Flojo software (Tree Star, Inc.).
GenBank/EMBL/DDBJ accession numbers
The GenBank/EMBL/DDBJ accession number for centriolin is AF513978
and for lamin A/C is X03444.
Online supplemental material
Supplemental videos (Videos 1–3) are available at http://www.jcb.org/cgi/
content/full/jcb.200301105/DC1. The supplemental videos show that cells
silenced for centriolin delay in cytokinesis, remain interconnected by per-
sistent intercellular bridges, re-enter mitosis while still interconnected, and
form multicellular syncytia. Some cells divide normally while others un-
dergo apparent apoptosis characterized by blebbing, rounding up, diminu-
tion in size, and loss of substrate attachment.
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